PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
US$Â 8,50
0,00%
(0,00) 1D
12 okt, 10:22:09 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor PTKFY genereren…
Beursw.
31,60Â bln.
Gem. vol.
1,94K
Volume
1,43K
52 wk hoog
US$Â 16,36
52 wk laag
US$Â 7,63
Bèta
0,09
Uitstaande aandelen
234,07Â mln.
Aantal medewerkers
13K
Beursw.
31,60Â bln.
Gem. vol.
1,94K
Volume
1,43K
52 wk hoog
US$Â 16,36
52 wk laag
US$Â 7,63
Bèta
0,09
Uitstaande aandelen
234,07Â mln.
Aantal medewerkers
13K
Nieuwsartikelen
Van webbronnen en nieuwspartners
ad-hoc-news.de
·
17 uur geleden
Buyback plans and results shaped Kalbe Farma stock review
ad-hoc-news.de
·
1 dag geleden
Kalbe Farma stock falls 14.56 percent to IDR 675.00
ad-hoc-news.de
·
1 dag geleden
Indo Premier sees Kalbe Farma stock earnings beating estimates
ad-hoc-news.de
·
2 dagen geleden
Kalbe Farma launches IDR 500 billion buyback while Kiwoom targets Kalbe Farma stock
Profiel
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Over PT Kalbe Farma Unsponsored Indonesia ADR